Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Advanced Materials (Deerfield Beach, Fla.)|September 23, 2020
Filament-Free Bulk Resistive Memory Enables Deterministic Analogue SwitchingYiyang Li, Elliot J Fuller, Joshua D Sugar, et al.
Journal of Neurosurgery|February 4, 2014
An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidityMark E Oppenlander, Andrew B Wolf, Laura A Snyder, et al.
Chemistry of Materials : a Publication of the American Chemical Society|June 16, 2020
Conformal Ultrathin Film Metal-Organic Framework Analogues: Characterization of Growth, Porosity, and Electronic TransportJonathan Lau, Ashley E Trojniak, Macy J Maraugha, et al.
Molecular Psychiatry|January 14, 2009
Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathwaysC Ditzen, J Varadarajulu, L Czibere, et al.
Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 27, 2022
Tunable Intervalence Charge Transfer in Ruthenium Prussian Blue Analog Enables Stable and Efficient Biocompatible Artificial SynapsesDonald A Robinson, Michael E Foster, Christopher H Bennett, et al.
ACS Nano|September 21, 2022
Imaging Phase Segregation in Nanoscale LiCoO2 Single ParticlesElliot J Fuller, David S Ashby, Celia Polop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastomaTracy T Batchelor, Paul Mulholland, Bart Neyns, et al.
Neuro-Oncology Advances|November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastomaTracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Pageof 11